It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Novartis AG ADR (NVS) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.31, or -0.33%, to $93.78. The Novartis AG ADR has recorded 6,128 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Novartis data show potential of remibrutinib as an oral treatment for chronic spontaneous urticaria providing significant symptom improvement as early as Week 2.
Novartis AG ADR is listed on the NYSE in the Healthcare sector while operating in the Drug Manufacturers – General industry. At the end of the last regular session, the stock closed at $94.09 and fluctuated between $94.17 as its day high and $92.91 as its day low. The current market capitalization of Novartis AG ADR is $187.56B. A total of 0.88 million shares were traded on the day, compared to an average of 1.37M shares.
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Novartis AG ADR pays an annual dividend of $3.54, resulting in a dividend yield of 3.76%, and it has a price to earnings (P/E) ratio of 25.33. NVS’s most recent ex-dividend date was 3/9/2023 when it declared a $3.4694 quarterly dividend that was paid in cash on 3/20/2023. Previously, the company paid the dividend on 3/17/2022 with an ex-dividend date of 3/8/2022. The NVS stock dividend was $1.1750 per share in cash.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for NVS in the last 3 months, the mean price target is $108.14 with high estimates of $122.31 and low estimates of $82.41. In terms of 52-week highs and lows, NVS has a high of $99.94 and a low of $75.68.
As of this writing, NVS has an earnings estimate of $1.65 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of $1.77 per share and a lower estimate of $1.58. The company reported an EPS of $1.83 in the last quarter, which was 8.90% higher than expectations of $1.68.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. NVS’s latest balance sheet shows that the firm has $28.33B in Cash & Short Term Investments as of fiscal 2021. There were $31.09B in debt and $30.21B in liabilities at the time. Its Book Value Per Share was $18.57, while its Total Shareholder’s Equity was $67.82B.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NVS is Buy with a score of 3.75.